Murgitroyd & Company opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Murgitroyd & Company

Patent Number:
Title:
Identification And Use Of Circulating Nucleic Acid Tumor Markers
Opposition Date:
Jan 26, 2024
Patent Number:
Title:
Connector For Connecting A Medical Injection Device To A Container
Opposition Date:
Oct 4, 2023
Patent Number:
Title:
Treatment Of Cancer Using Chimeric Antigen Receptor
Applicant:
Opposition Date:
Sep 13, 2023
Patent Number:
Title:
Compositions And Methods Of Cellular Immunotherapy
Opposition Date:
Sep 13, 2023
Patent Number:
Title:
Cell Culture Medium Comprising Small Peptides
Opposition Date:
Aug 2, 2023
Patent Number:
Title:
Crystalline Forms Of Tapentadol Salts And Process For Preparation Thereof
Opposition Date:
Oct 6, 2021
Patent Number:
Title:
A Polypropylene Cap Or Film Composition
Opposition Date:
Aug 18, 2021
Patent Number:
Title:
Identification And Use Of Circulating Nucleic Acid Tumor Markers
Opposition Date:
May 19, 2021
Patent Number:
Title:
Method Of And Apparatus For Preparing Samples For Imaging Or Diffraction Experiments Under Cryogenic Conditions
Opposition Date:
Mar 17, 2021
Patent Number:
Title:
Method And Arrangement For Removing A Liner Below Surface
Opposition Date:
Feb 12, 2021

Want to track Murgitroyd & Company?

Feel free to send us a message here and we will get back to you